Cargando…

Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs

PURPOSE: Plasma-Lyte is a balanced, crystalloid intravenous fluid which has been shown to avoid the hyperchloremic metabolic acidosis associated with 0.9% sodium chloride. Data on physical, pH and chemical compatibility with other medicines are essential. METHODS: The compatibility of adrenaline, do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammond, Sophie, Wignell, Andrew, Cooling, Paul, Barrett, David A., Davies, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311557/ https://www.ncbi.nlm.nih.gov/pubmed/32577941 http://dx.doi.org/10.1186/s40635-020-00311-5

Ejemplares similares

Plasma-Lyte 148: A clinical review
por: Weinberg, Laurence, et al.
Publicado: (2016)

The effects of Plasma-Lyte 148 solution on blood coagulation: an in-vitro, volunteer study using rotational thromboelastometry
por: Shin, Hyun-Jung, et al.
Publicado: (2018)

Plasma-Lyte-148 Versus Normal Saline 0.9% in Diabetic Ketoacidosis Management: A Review
por: Othman, Mutaz I, et al.
Publicado: (2023)

Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care
por: Nilsson, Niklas, et al.
Publicado: (2022)

Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution
por: Davies, Paul G, et al.
Publicado: (2011)

Lyte at the end of the tunnel
por: Anzenberg, Paula, et al.
Publicado: (2023)

The Plasma-Lyte 148 versus Saline (PLUS) statistical analysis plan: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality
por: Billot, Laurent, et al.
Publicado: (2023)

Plasma-lyte(®) as dialysate for CRRT: institution of a new therapy and initial evaluation
por: McCunn, M, et al.
Publicado: (2002)

The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial
por: Weinberg, Laurence, et al.
Publicado: (2021)

Don't Take It 'Lytely': A Case of Acute Tetany
por: Johnson, McKenna M, et al.
Publicado: (2019)

A randomized trial of Plasma-Lyte A and 0.9 % sodium chloride in acute pediatric gastroenteritis
por: Allen, Coburn H., et al.
Publicado: (2016)

Effect of Normal Saline versus PlasmaLyte on Coagulation and Metabolic Status in Patients Undergoing Neurosurgical Procedures
por: Arora, Vandna, et al.
Publicado: (2023)

Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO)
por: Hayes, Wesley, et al.
Publicado: (2022)

0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial
por: Raman, Sainath, et al.
Publicado: (2021)

Impact of Plasma-Lyte pH 7.4 on acid-base status and hemodynamics in a model of controlled hemorrhagic shock
por: Noritomi, Danilo Teixeira, et al.
Publicado: (2011)

Randomized Trial of Gatorade/Polyethylene Glycol With or Without Bisacodyl and NuLYTELY for Colonoscopy Preparation
por: Gerard, David P, et al.
Publicado: (2012)

Effects of Plasma-Lyte.½ and 0.9% saline in renal function after deceased-donor kidney transplant: a randomized controlled trial
por: do Nascimento Junior, Paulo, et al.
Publicado: (2021)

Development of a LytE‐based high‐density surface display system in Bacillus subtilis
por: Chen, Chyi‐Liang, et al.
Publicado: (2008)

The Effect on Serum Electrolytes in Patients Undergoing Elective Craniotomy for Supratentorial Brain Tumors Using PlasmaLyte A and Normal Saline as Intravenous Replacement Fluid
por: Shrivastava, Priyanka, et al.
Publicado: (2023)

Assessment of renal hemodynamic toxicity of fluid challenge with 0.9% NaCl compared to balanced crystalloid (PlasmaLyte(®)) in a rat model with severe sepsis
por: Olivier, Pierre-Yves, et al.
Publicado: (2017)

0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial
por: Williams, Vijai, et al.
Publicado: (2020)

A Comparative Study of Peri-Operative Fluid Therapy With Ringer Lactate and PlasmaLyte in Children Undergoing Intra-Abdominal Surgery: A Randomized Control Trial
por: Priyanka, Andal, et al.
Publicado: (2023)

Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation
por: Collins, Michael G., et al.
Publicado: (2020)

Perioperative Plasma-Lyte use reduces the incidence of renal replacement therapy and hyperkalaemia following renal transplantation when compared with 0.9% saline: a retrospective cohort study
por: Adwaney, Anamika, et al.
Publicado: (2017)

Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement – a randomized trial
por: Østergaard, A. M., et al.
Publicado: (2021)

148th SPSC Meeting
Publicado: (2023)

148th LHCC Meeting
Publicado: (2021)

Band structure in /sup 148/Ce from the decay of mass separated /sup 148/La
por: Gill, R L, et al.
Publicado: (1981)

Synapse too exclusive for CD148
por: LeBrasseur, Nicole
Publicado: (2003)

Collaboration Agreement No. Kl148/AB
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2005)

Minutes of the 148th Meeting of the LHCC
por: CERN. Geneva. Large Hadron Collider Experiments Committee, et al.
Publicado: (2021)

The Role of Mir-148a in Cancer
por: Li, Yue, et al.
Publicado: (2016)

Health Tract, No. 148: Summer Drinks
Publicado: (1863)

Health Tract, No. 148: Summer Drinks
Publicado: (1865)

148th IAU Symposium on Magellanic Clouds
por: Haynes, Raymond, et al.
Publicado: (1991)

Defect and diffusion forum vols 148-149
por: Fisher, David J
Publicado: (1997)

Cardiac Infarction: A Study of 148 Cases
por: Harrington, A. W., et al.
Publicado: (1933)

Cumulative subject index volumes 148–155()
Publicado: (1986)

miR-148a targets XBP1 to regulate trophoblast apoptosis induced by plasma reticulum stress in preeclampsia
por: Li, Na, et al.
Publicado: (2022)

Heritability of Cardiovascular and Personality Traits in 6,148 Sardinians
por: Pilia, Giuseppe, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_dqncffans9goosvnc7ka49m9h9